NDC 51662-1448
LEXISCAN(R) (REGADENOSON)
Lexiscan(r) (regadenoson)
LEXISCAN(R) (REGADENOSON) is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Regadenoson.
| Product ID | 51662-1448_99640071-4db3-9317-e053-2995a90a610d |
| NDC | 51662-1448 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LEXISCAN(R) (REGADENOSON) |
| Generic Name | Lexiscan(r) (regadenoson) |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2019-12-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022161 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | REGADENOSON |
| Active Ingredient Strength | 0 mg/mL |
| Pharm Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |